Pediatric pearls: Use of steroids for erythema multiforme in children

Canadian Family Physician

Volumn 51, Issue NOV., 2005, Pages 1481-1483

  Yeung, Alfred K ^a   Goldman, Ran D ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CORTICOSTEROID; MACROLIDE; METHYLPREDNISOLONE; PENICILLIN DERIVATIVE; PREDNISONE; SULFONAMIDE; TETRACYCLINE; GLUCOCORTICOID;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHILD CARE; CONVALESCENCE; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG MECHANISM; ERYTHEMA MULTIFORME; GASTROINTESTINAL HEMORRHAGE; HERPES SIMPLEX; HUMAN; HYPERSENSITIVITY; IMMUNOREGULATION; IMMUNOSTIMULATION; INFECTION; INFECTION RISK; MYCOPLASMA PNEUMONIA; PATHOGENESIS; PNEUMONIA; STEVENS JOHNSON SYNDROME; CHILD; REVIEW;

CHILD; ERYTHEMA MULTIFORME; GLUCOCORTICOIDS; HUMANS;

EID: 28444443823     PISSN: 0008350X     EISSN: 0008350X     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Von Hebra F. Atlas der Hautkrankheiten. Vienna, Austria: Kaiserliche Akademie der Wissenchaften Wien; 1866.
2. Weston WL. What is erythema multiforme? Pediatr Ann 1996;25:107-9.
3. Huff JC, Weston WL, Tonnesen MG. Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol 1983;8:763-75.
4. Darmstadt GL, Cohen B. Pathological cases of the month: erythema multiforme. Arch Pediatr Adolesc Med 1994;148(4):429-30.
5. Stampien TM, Schwartz RA. Erythema multiforme. Am Fam Physician 1992;46(4):1171-6.
6. Renfro L, Grant-Kels JM, Feder HM Jr, Daman LA. Controversy: are systemic steroids indicated in the treatment of erythema multiforme? Pediatr Dermatol 1989;6(1):43-50.
7. Villiger RM, von Vigier RO, Ramelli GP, Hassink RI, Bianchetti MG. Precipitants in 42 cases of erythema multiforme. Eur J Pediatr 1999;158(11):929-32.
8. Lemak M, Duvic M, Bean S. Oral acyclovir for the prevention of herpes-associated erythema multiforme. J Am Acad Dermatol 1986;15:50-4.
9. Martinez AE, Atherton DJ. High-dose systemic corticosteroids can arrest recurrences of severe mucocutaneous erythema multiforme. Pediatr Dermatol 2000;17(2):87-90.
10. Pitzalis C, Pipitone N, Bajocchi G, Hall M, Goulding N, Lee A, et al. Corticosteroids inhibit lymphocyte binding to endothelium and intercellular adhesion: an additional mechanism for their anti-inflammatory and immunosuppressive effect. J Immunol 1997;158(10):5007-16.
11. Rasmussen JE. Erythema multiforme in children: response to treatment with systemic corticosteroids. Br J Dermatol 1976;95:181-6.
12. Ginsburg CM. Stevens-Johnson syndrome in children. Pediatr Infect Dis 1982;1:155-8.
13. Prendiville JS, Hebert AA, Greenwald MJ, Esterly NB. Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. J Pediatr 1989;115(6):881-7.
14. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333(24):1600-7.
15. Weston WL. Steroids in erythema multiforme. Pediatr Dermatol 2000;17(1):75-83.
16. Prendiville JS. Erythema multiforme and steroids. Pediatr Dermatol 2000;17(1):75-83.